Longitudinally Extensive Transverse Myelitis with Aquaporin-4 Antibody Positivity in Renal Cell Carcinoma: Rare Occurrence

被引:6
|
作者
Mahale, Rohan R. [1 ]
Mehta, Anish [1 ]
Buddaraju, Kiran [1 ]
Javali, Mahendra [1 ]
Shankar, Abhinandan K. [1 ]
John, Aju Abhraham [1 ]
Srinivasa, Rangasetty [1 ]
机构
[1] MS Ramaiah Med Coll & Hosp, Dept Neurol, Bangalore 560054, Karnataka, India
关键词
Antibody; aquaporin-4; renal cell carcinoma; transverse myelitis; NEUROMYELITIS-OPTICA;
D O I
10.4103/0028-3886.266293
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The occurrence of longitudinally extensive transverse myelitis (LETM) in an elderly patient should evoke search for underlying systemic malignancy. Intramedullary spinal cord metastases and paraneoplastic myelopathy are the most common etiology for LETM in patients with systemic malignancy. The occurrence of LETM in association with renal cell carcinoma with aquaporin-4 (AQP4) antibody positivity has not been reported. We report an elderly woman who presented with acute paraplegia and was diagnosed as having LETM with AQP4 positivity and renal cell carcinoma.
引用
收藏
页码:1087 / 1089
页数:3
相关论文
共 50 条
  • [41] Renal cell carcinoma metastasis to the parathyroid gland: A very rare occurrence
    Ofo, Enyinnaya
    Mandavia, Rishi
    Jeannon, Jean-Pierre
    Odell, Edward
    Simo, Ricard
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2014, 5 (07): : 378 - 380
  • [42] A rare co-occurrence of tubulocystic and clear cell type renal cell carcinoma
    Saha, Kaushik
    Sengupta, Moumita
    CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (04): : 353 - 355
  • [43] Concentrations of B cell-activating factor, aquaporin-4 antibody and brain-derived neurotrophic factor in neuromyelitis optica spectrum disorder
    Li, Suping
    Fu, Jing
    Xu, Fei
    Yu, Liang
    Yu, Qian
    Yu, Nengwei
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2023, 48 (01): : 32 - 38
  • [44] Accuracy of the Fluorescence-Activated Cell Sorting Assay for the Aquaporin-4 Antibody (AQP4-Ab): Comparison with the Commercial AQP4-Ab Assay Kit
    Yang, Jiwon
    Kim, Sung Min
    Kim, Yoo-Jin
    Cheon, So Young
    Kim, Boram
    Jung, Kyeong Cheon
    Park, Kyung Seok
    PLOS ONE, 2016, 11 (09):
  • [45] Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders
    S. Jarius
    F. Paul
    K. Ruprecht
    B. Wildemann
    Journal of Neurology, 2012, 259 : 2743 - 2745
  • [46] An exceedingly rare simultaneous incidental occurrence of synchronous primary malignancies; Invasive Ductal Carcinoma and Renal Cell Carcinoma in a male - A Case Report
    Al Laham, Omar
    Atia, Fareed
    Ibrahim, Dana
    Shaheen, Jack
    Hokouk, Bashir
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2022, 96
  • [47] A rare co-occurrence of renal cell carcinoma, bilateral adrenal metastasis and inferior vena cava thrombus: A case report
    Alsaman, Muhamad Zakaria Brimo
    Almerhej, Merhej
    Qut, Alaa
    Al Nahhas, Zaher
    Alia, Louei
    Nahas, Mohamad Ali
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2023, 110
  • [48] Concurrent Eosinophilic Solid and Cystic Renal Cell Carcinoma and Angiomyolipoma With Epithelial Cysts in the Setting of Tuberous Sclerosis Complex: A Rare Synchronous Occurrence of 2 Distinct Entities
    Cho, Woo Cheal
    Collins, Katrina
    Mnayer, Laila
    Cartun, Richard W.
    Earle, Jonathan S.
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2019, 27 (07) : 804 - 811
  • [49] Eradication of established renal cell carcinoma by a combination of 5-fluorouracil and anti-4-1BB monoclonal antibody in mice
    Ju, Seong-A
    Cheon, Sang-Hyeon
    Park, Sang-Min
    Tam, Nyuen Quang
    Kim, Young Min
    An, Won G.
    Kim, Byung-Sam
    INTERNATIONAL JOURNAL OF CANCER, 2008, 122 (12) : 2784 - 2790
  • [50] Anti-4-1BB antibody-based combination therapy augments antitumor immunity by enhancing CD11c+CD8+ T cells in renal cell carcinoma
    Ju, Seong-A
    Park, Sang-Min
    Joe, Yeonsoo
    Chung, Hun
    An, Won
    Kim, Byung-Sam
    ONCOLOGY LETTERS, 2022, 23 (02)